2m 2m 2m 2m 2m 2m 2m
INOVIO PHARMA (INO)
NASDAQ
$0.85+$0.06 (+7.26%)
Price as of Oct 22, 2026 7:58 PM EDT- $82.2MMarket Cap
- -64.18%1-Year Change
- BiotechnologyIndustry
INOVIO PHARMA (INO)
$0.85+$0.06 (+7.26%)
INO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.80 | ||
Change | -$0.21 (-21.26%) | ||
Open | $1.06 | ||
High | $1.09 | ||
Low | $0.80 | ||
Previous Close | $1.01 | ||
Volume | 11,649,288 | ||
30-Day Average Volume | 3,585,983 | ||
1-Week Change | -19.34% | ||
1-Month Change | -35.86% | ||
1-Year Change | -64.18% | ||
3-Year Change | -85.90% | ||
5-Year Change | -99.06% | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $49.4M | ||
Market Cap | $82.2M | ||
Enterprise Value | $50.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$6.0M | ||
EBITDA | -$5.7M | ||
Net Working Capital | -$1,810.00 | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 19 | ||
P/E | -11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/25/2024 | ||
Earnings & Revenue